Albuterol 1 — Class II drug recall D-0514-2020
Terminated recall by Integrated Health Concepts Inc. dba Conversio Health, reported 2019-11-27, distributed nationwide. Lack of Processing Controls
| Recall number | D-0514-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Integrated Health Concepts Inc. dba Conversio Health, San Luis Obispo, CA, United States |
| Recall initiated | 2019-11-12 |
| Classified | 2019-11-19 |
| Reported by FDA | 2019-11-27 |
| Terminated | 2020-05-28 |
| Distributed | Nationwide (US) |
Product
Albuterol 1.25mg / Ipratropium 0.5mg/ Budesonide 0.25mg, 3ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA 93401.
Reason for recall
Lack of Processing Controls
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0514-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.